These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1808313)

  • 1. [Neutralized continuous ambulatory peritoneal dialysis dialysate].
    Yamamoto T; Sakakura T; Yamakawa M
    Nihon Rinsho; 1991 Dec; 49 Suppl():532-7. PubMed ID: 1808313
    [No Abstract]   [Full Text] [Related]  

  • 2. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Replacement of the peritoneal dialysis catheter in persistent peritonitis in continuous ambulatory peritoneal dialysis].
    Marichal JF; Faller B; Mengus C; Wagner JD; Frey G
    Nephrologie; 1985; 6(1):7-10. PubMed ID: 4000380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of ceftazidime injected peritoneally in continuous ambulatory peritoneal dialysis].
    Ryckelynck JP; Vergnaud M; Hurault de Ligny B; Allouche G; Malbruny B; Morel C
    Pathol Biol (Paris); 1986 May; 34(5):328-31. PubMed ID: 3534700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
    Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is interleukin-6 concentration in the dialysate of continuous ambulatory peritoneal dialysis patients a prognostic parameter in peritonitis?
    Fiedler R; Schneider I; Fischer K; Deuber HJ; Osten B
    Adv Perit Dial; 2001; 17():159-62. PubMed ID: 11510267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Continuous ambulatory peritoneal dialysis--current concepts after 10 years' experience].
    Rottembourg J; Babronski C
    Ther Umsch; 1988 Dec; 45(12):900-7. PubMed ID: 3065971
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical effects of long-term use of neutralized dialysate for continuous ambulatory peritoneal dialysis.
    Yamamoto T; Sakakura T; Yamakawa M; Horiuchi N; Hirata S; Iritani Y; Nishitani H; Kim M; Kishimoto T; Chiku T
    Nephron; 1992; 60(3):324-9. PubMed ID: 1565185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between nitric oxide and oxidative stress in continuous ambulatory peritoneal dialysis patients with peritonitis.
    Duranay M; Yilmaz FM; Yilmaz G; Akay H; Parpucu H; Yücel D
    Scand J Clin Lab Invest; 2007; 67(6):654-60. PubMed ID: 17852815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience regarding reduction of peritonitis rates in continuous ambulatory peritoneal dialysis.
    Faller B; Genestier S; Bodenreider O; Brignon P; Boess G
    Perit Dial Int; 1993; 13 Suppl 2():S319-21. PubMed ID: 8399598
    [No Abstract]   [Full Text] [Related]  

  • 11. CD40 ligand expression on macrophages during peritonitis in continuous ambulatory peritoneal dialysis patients.
    Yang X; Ye RG; Kong QY; Yang QQ; Gao Y; Zhong JH; Wang T
    Adv Perit Dial; 2000; 16():213-5. PubMed ID: 11045296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritonitis in continuous cycling peritoneal dialysis.
    Diaz-Buxo JA; Crawford TL
    Adv Perit Dial; 2002; 18():161-4. PubMed ID: 12402611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial peritoneal defence in automated peritoneal dialysis: advantages of tidal over continuous cyclic peritoneal dialysis?
    de Fijter CW; Verbrugh HA; Oe PL; Heezius EC; Verhoef J; Donker AJ
    Nephrol Dial Transplant; 1994; 9(2):156-62. PubMed ID: 8190329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid-base balance in continuous ambulatory peritoneal dialysis.
    Schleifer CR; Teehan BP; Reichard GA; Sigler MH; Cupit M; Haff AC
    Proc Clin Dial Transplant Forum; 1980; 10():100-4. PubMed ID: 7346838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of peritonitis in continuous ambulatory peritoneal dialysis].
    Ryckelynck JP; Hurault de Ligny B; Levaltier B; Batho JM; Berthaux M
    Nephrologie; 1989; 10 Suppl():46-9. PubMed ID: 2510034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reduction in the incidence of peritonitis in continuous ambulatory peritoneal dialysis using a simple microbiological dialysate-check].
    Oliveri M; Záruba K
    Schweiz Rundsch Med Prax; 1982 Oct; 71(43):1696-1700. PubMed ID: 7188555
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis.
    Montenegro J; Saracho R; Gallardo I; Martínez I; Muñoz R; Quintanilla N
    Nephrol Dial Transplant; 2007 Jun; 22(6):1703-8. PubMed ID: 17405794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritonitis complicating continuous ambulatory peritoneal dialysis.
    Swartz RD
    Compr Ther; 1988 Jan; 14(1):24-30. PubMed ID: 3277763
    [No Abstract]   [Full Text] [Related]  

  • 19. The long-term effects of single peritonitis episodes on peritoneal equilibration test results in continuous ambulatory peritoneal dialysis patients.
    Hung SY; Chung HM
    Adv Perit Dial; 2001; 17():196-9. PubMed ID: 11510273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis of peritonitis in continuous ambulatory peritoneal dialysis (CAPD) by a simple microbiological patient self-check.
    Záruba K; Oliveri M
    Proc Eur Dial Transplant Assoc; 1981; 18():275-9. PubMed ID: 7036152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.